Sponsor of the Day:
Jerkmate
https://www.globalmediawatch.com/article/907144160-disc-medicine-announces-oral-presentation-of-data-from-rally-mf-phase-2-trial-of-disc-0974-in-patients-with-myelofibrosis-and-anemia-at-the-american
Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in...
phase 2 trialmedicine announcesoral presentationdiscdata
https://pharmatimes.com/news/transgene-completes-randomisation-in-phase-2-trial-of-tg4050/
Transgene completes randomisation in phase 2 trial of tg4050 - PharmaTimes
Apr 13, 2026 - Company expects two‑year dfs data by q1 2028
phase 2 trialtransgenecompletesrandomisationpharmatimes
https://www.statnews.com/2026/03/16/structure-therapeutics-obesity-pill-aleniglipron-weight-loss/
Structure's obesity pill shows weight loss promise in Phase 2 trial
Mar 16, 2026 - The company is planning a Phase 3 study after the pill, aleniglipron, helped patients lose a significant amount of weight.
phase 2 trialobesity pillweight lossstructureshows